Randomised controlled trial to assess the impact of hospital–community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs—a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol
Introduction Drug-related problems (DRPs) associated with oral anticancer drugs are frequent and require a new healthcare organisation to manage them on an outpatient basis. The aim of this article is to present the study protocol of the Drug Related problems in Oncology Practice (DROP) randomised c...
Saved in:
| Main Authors: | Patrick Tilleul, Christophe Bardin, Bertrand Pourroy, Florence Ranchon, Catherine Rioufol, Laure Huot, Isabelle Madelaine, Jean Louis Cazin, François Lemare |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e094825.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01) -
Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01) -
Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment
by: Yu. V. Dinikina, et al.
Published: (2024-01-01) -
Modifying drug dosages in oncology: immense need for innovative oncology treatments
by: Karamitrousis Evangelos, et al.
Published: (2024-11-01) -
Observational study of drug-drug interactions in oncological inpatients
by: María Sacramento Díaz-Carrasco, et al.
Published: (2018-01-01)